EGFR and colorectal carcinoma: These changes, which are made during chemotherapeutic regimens such as 5-FU, have been observed in the human CRC cell lines.66 Mir-7 is capable of suppressing EGRF in vitro and making CRC patients, who develop resistance to EGFR inhibitors such as cetuximab, regain sensitivity to these drugs.6